Saira Butt , Amy B. Kressel , Brian L. Haines , Katherine Merrill , Amber M. Ryan , Kenneth C. Gavina , Bree Weaver , Michael Kays , Molly Tieman , Margaret Muciarelli , Phillip Clapham
{"title":"Rapid implementation of a clinical decision-support workflow during the national blood culture bottle shortage","authors":"Saira Butt , Amy B. Kressel , Brian L. Haines , Katherine Merrill , Amber M. Ryan , Kenneth C. Gavina , Bree Weaver , Michael Kays , Molly Tieman , Margaret Muciarelli , Phillip Clapham","doi":"10.1016/j.infpip.2024.100417","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The United States Food and Drug Administration recently announced a national blood culture (BC) bottle shortage; the exact date of restoration is still being determined.</div></div><div><h3>Aim</h3><div>Implement a workflow to mitigate the BC bottle shortage at our hospital.</div></div><div><h3>Methods</h3><div>We created the following clinical decision support workflow in electronic medical record to help mitigate BC bottle use: (a) limit to two BC in 24 hours, (b) only repeat BC if 72 hours have passed from the prior sets, (c) do not repeat BC for coagulase-negative <em>Staphylococcus</em> bacteremia when considered a contaminant (i.e., no implanted vascular device), (d) do not repeat BC for <em>Streptococcus</em> bacteremia, (e) do not repeat cultures for Gram-negative rod bacteremia unless an unknown source, immunosuppression, or clinical worsening.</div></div><div><h3>Findings</h3><div>Post implementation, our weekly average BC bottle use decreased to 29.5%.</div></div><div><h3>Conclusion</h3><div>Within three weeks of the BC bottle shortage announcement, we successfully deployed evidence-based BC restrictions in the electronic medical record (EMR), reducing our BC orders by 29.5%. We encourage others to consider and potentially replicate our workflow to contribute to diagnostic stewardship.</div></div>","PeriodicalId":33492,"journal":{"name":"Infection Prevention in Practice","volume":"6 4","pages":"Article 100417"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Prevention in Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590088924000817","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The United States Food and Drug Administration recently announced a national blood culture (BC) bottle shortage; the exact date of restoration is still being determined.
Aim
Implement a workflow to mitigate the BC bottle shortage at our hospital.
Methods
We created the following clinical decision support workflow in electronic medical record to help mitigate BC bottle use: (a) limit to two BC in 24 hours, (b) only repeat BC if 72 hours have passed from the prior sets, (c) do not repeat BC for coagulase-negative Staphylococcus bacteremia when considered a contaminant (i.e., no implanted vascular device), (d) do not repeat BC for Streptococcus bacteremia, (e) do not repeat cultures for Gram-negative rod bacteremia unless an unknown source, immunosuppression, or clinical worsening.
Findings
Post implementation, our weekly average BC bottle use decreased to 29.5%.
Conclusion
Within three weeks of the BC bottle shortage announcement, we successfully deployed evidence-based BC restrictions in the electronic medical record (EMR), reducing our BC orders by 29.5%. We encourage others to consider and potentially replicate our workflow to contribute to diagnostic stewardship.
背景美国食品和药物管理局最近宣布全国性血液培养(BC)瓶短缺;具体恢复日期仍在确定中。方法我们在电子病历中创建了以下临床决策支持工作流程,以帮助减少 BC 瓶的使用:(a) 限制在 24 小时内进行两次 BC,(b) 只有在距离上一次 BC 已过去 72 小时时才重复 BC,(c) 如果认为凝固酶阴性葡萄球菌菌血症是污染物(即:没有植入血管装置),则不重复 BC、结论在 BC 瓶短缺公告发布后的三周内,我们成功地在电子病历 (EMR) 中部署了循证 BC 限制,将 BC 订单减少了 29.5%。我们鼓励其他人考虑并有可能复制我们的工作流程,为诊断监管做出贡献。